Skip to main content
Hauptrubriken
CME Facharzt-Training Webinare Zeitschriften Bücher e.Medpedia Podcast
Service
Jobbörse Info & Hilfe
Fachgebiete
Anästhesiologie Allgemeinmedizin Arbeitsmedizin Augenheilkunde Chirurgie Dermatologie Gynäkologie und Geburtshilfe HNO Innere Medizin Kardiologie Neurologie Onkologie und Hämatologie Orthopädie und Unfallchirurgie Pädiatrie Pathologie Psychiatrie Radiologie Rechtsmedizin Urologie Zahnmedizin
Themen
Klimawandel und Gesundheit Neues aus dem Markt COVID-19 Praxis und Beruf Seltene Erkrankungen GOÄ & EBM Panorama
Sammlungen
Kasuistiken Algorithmen & Infografiken Blickdiagnosen Arthropedia FlapFinder (für Dermatochirurgen) Videos Kongressberichterstattung Medizin für Apothekerinnen und Apotheker Für Ärztinnen und Ärzte in Weiterbildung Für Medizinstudierende

Live-Webinar "Chronische Unterbauch- und Viszeralschmerzen in der Praxis managen"

Das Thema chronische Unterbauch- und Viszeralschmerzen wird im Live-Webinar am 7. Mai von 17.30 bis 19 Uhr aus internistischer, gynäkologischer und psychologisch-neurowissenschaftlicher Perspektive beleuchtet. Besprochen werden krankheitsbedingte Ursachen, Mechanismen der kognitiven Schmerzmodulation sowie mögliche Therapieoptionen. Die Fortbildung ist mit 2 CME-Punkten zertifiziert. Melden Sie sich jetzt an!
Erweiterte Suche
Anmelden
nach oben
Journal of Mammary Gland Biology and Neoplasia
Erschienen in: Journal of Mammary Gland Biology and Neoplasia 2/2019

28.11.2018

A Comparative Review of Mixed Mammary Tumors in Mammals

verfasst von: Eman S. A. Saad, Jacqueline S. Y. Lam, Awf A. Al-Khan, Mourad Tayebi, Michael J. Day, Samantha J. Richardson, Janine A. Danks

Erschienen in: Journal of Mammary Gland Biology and Neoplasia | Ausgabe 2/2019

Einloggen, um Zugang zu erhalten

Abstract

Mixed tumors are characterized by the histological identification of two or more cell types. Commonly, a mixture of epithelial and myoepithelial cells is included in abundant stroma, which can consist of myxoid, chondroid or bony matrices. Spontaneously arising mixed tumors are rare lesions in the human breast but are common in human salivary glands and canine mammary glands. Subtle histopathological characteristics and overlapping attributes of malignant lesions with other benign lesions can lead to a diagnostic challenge. Mixed tumors can present as benign or malignant. While malignant mixed tumors are quite rare in the human breast they have a poor prognosis. Benign mixed mammary tumors occur more frequently in female dogs than in humans and are usually associated with a good prognosis. This review will provide a comprehensive overview of mixed mammary tumors, across various mammalian species.
Literatur
1.
Jungbluth AA, Antonescu CR, Busam KJ, Iversen K, Kolb D, Coplan K, et al. Monophasic and biphasic synovial sarcomas abundantly express cancer/testis antigen NY-ESO-1 but not MAGE-A1 or CT7. Int J Cancer. 2001;94(2):252–6.CrossRefPubMed
2.
Voz ML, Van de Ven WJ, Kas K. First insights into the molecular basis of pleomorphic adenomas of the salivary glands. Adv Den Res. 2000;14:81–3.CrossRef
3.
Giroux V, Rustgi AK. Metaplasia: tissue injury adaptation and a precursor to the dysplasia–cancer sequence. Nat Rev Cancer. 2017;17(10):594–604.CrossRefPubMedPubMedCentral
4.
5.
Genelhu MC, Cardoso SV, Gobbi H. Cassali GD. A comparative study between mixed-type tumours from human salivary and canine mammary glands. BMC Cancer. 2007;7(1):218.CrossRefPubMedPubMedCentral
6.
Dieci MV, Orvieto E, Dominici M, Conte P, Guarneri V. Rare breast cancer subtypes: histological, molecular, and clinical peculiarities. Oncologist. 2014;19(8):805–13.CrossRefPubMedPubMedCentral
7.
Pittenger MF, Mackay AM, Beck SC, Jaiswal RK, Douglas R, Mosca JD, et al. Multilineage potential of adult human mesenchymal stem cells. Science. 1999;284(5411):143–7.CrossRefPubMed
8.
9.
Jain S, Hasan S, Vyas N, Shah N, Dalal S. Pleomorphic adenoma of the parotid gland: report of a case with review of literature. Ethiop J Health Sci. 2015;25(2):189–94.CrossRefPubMedPubMedCentral
10.
Antony J, Gopalan V, Smith RA, Lam AKY. Carcinoma ex pleomorphic adenoma: a comprehensive review of clinical, pathological and molecular data. Head Neck Pathol. 2012;6(1):1–9.CrossRefPubMed
11.
Reid-Nicholson M, Bleiweiss I, Pace B, Azueta V, Jaffer S. Pleomorphic adenoma of the breast. Arch Pathol Lab Med. 2003;127(4):474–7.PubMed
12.
Abbasi MA, Mahmood H, Faheem M, Khan KA, Irfan J. Carcinosarcoma of the breast. J Coll Physicians Surg Pak. 2012;22:333–4.PubMed
13.
14.
Kanthan R, Senger J-L. Uterine Carcinosarcomas (malignant mixed Müllerian Tumours): a review with special emphasis on the controversies in management. Obstet Gynecol Int J. 2011;2011:470795.
15.
Massinde AN, Rumanyika R, Kihunrwa A, Rambau P, Magoma M. Malignant mixed Mullerian tumour of the prolapsed cervix: a case report. Tanzan J Health Res. 2012;14(2):158–61.CrossRefPubMed
16.
Shibata R, Umezawa A, Takehara K, Aoki D, Nozawa S, Hata J. Primary carcinosarcoma of the vagina. Pathol Int. 2003;53(2):106–10.CrossRefPubMed
17.
George EM, Herzog TJ, Neugut AI, Lu Y-S, Burke WM, Lewin SN, et al. Carcinosarcoma of the ovary: natural history, patterns of treatment, and outcome. Gynecol Oncol. 2013;131(1):42–5.CrossRefPubMedPubMedCentral
18.
Ko ML, Jeng CJ, Huang SH, Shen J, Tzeng CR, Chen SC. Primary peritoneal carcinosarcoma (malignant mixed mullerian tumor): report of a case with five-year disease free survival after surgery and chemoradiation and a review of literature. Acta Oncol. 2005;44(7):756–60.CrossRefPubMed
19.
Gao S, Huang L, Dai S, Chen D, Dai R, Shan Y. Carcinosarcoma of the gallbladder: a case report and review of the literature. Int J Clin Exp Pathol. 2015;8(6):7464–9.PubMedPubMedCentral
20.
Roh MS, Huh GY, Hong SH. Primary Carcinosarcoma of the skin. Korean J Pathol. 2001;35(5):444–6.
21.
Braham E, Rejeb HB, Aouadi S, Kilani T, El Mezni F. Pulmonary carcinosarcoma with heterologous component: report of two cases with literature review. Ann Transl Med. 2014;2(4):41.PubMedPubMedCentral
22.
Au JT, Sugiyama G, Wang H, Nicastri A, Lee D, Ko W, et al. Carcinosarcoma of the oesophagus – a rare mixed type of tumor. J Surg Case Rep. 2010;2010(7):7.CrossRefPubMedPubMedCentral
23.
Shim HJ, Hong YK, Kim S-J, Choi YJ, Kang JG. Carcinosarcoma on ascending colon found by bowel perforation: a case report. J Korean Soc Coloproctol. 2010;26(5):368–72.CrossRefPubMedPubMedCentral
24.
Oymaci E, Argon A, Coskun A, Ucar AD, Carti E, Erkan N, et al. Pancreatic carcinosarcoma: case report of a rare type of pancreatic neoplasia. Jop. 2013;14(2):212–5.PubMed
25.
26.
Auler P, Bertagnolli A, Ferreira E, Campos G, Dias AP, Campos C, et al. Myeloid metaplasia in canine mixed mammary tumors: occurrence and characterization. Vet Q. 2011;31(4):173–7.CrossRefPubMed
27.
28.
Salas G, Roman O, Gutiérrez dı́az-ceballos M, Constantino F. Lung carcinosarcoma in a dog: gross and microscopic examination. Vet J. 2002;163(3):331–4.CrossRefPubMed
29.
Perez-Martinez C, RA GF, LE RA, Perez-Perez V, Gonzalez N, Garcia-Iglesias M. Malignant fibrous histiocytoma (giant cell type) associated with a malignant mixed tumor in the salivary gland of a dog. Vet Pathol. 2000;37(4):350–3.CrossRefPubMed
30.
Moisan PG, Watson GL. Ceruminous gland tumors in dogs and cats: a review of 124 cases. J Am Anim Hosp Assoc. 1996;32(5):448–52.CrossRefPubMed
31.
Hirai T, Mubarak M, Kimura T, Ochiai K, Itakura C. Apocrine gland tumor of the eyelid in a dog. Vet Pathol. 1997;34(3):232–4.CrossRefPubMed
32.
Paniago JDG, Vieira ALS, Ocarino NM, França SA, Malm C, Cassali GD, et al. Mammary carcinosarcoma in cat: a case report. Arq Bras Med Vet Zootec. 2010;62:812–5.CrossRef
33.
Boos GS, Casagrande RA, Rolim VM, Watanabe TTN, Wouters F. Souza SOd, et al. mammary carcinosarcoma in a cat: anatomopathological and immunohistochemical characterization. Acta Sci Vet. 2011;39(4):1000.
34.
Yamamoto R, Suzuki K, Uchida K, Onda N, Shibutani M, Mitsumori K. Pancreatic carcinosarcoma in a cat. J Comp Pathol. 2012;147(2–3):223–6.CrossRefPubMed
35.
Almeida AP, Malm C, Lavalle G, Cassali GD, Santos RL, Paixão TA. Salivary gland carcinosarcoma in a dog. Braz J Vet Pathol. 2017;3(2):137–41.
36.
Cavicchioli L, Ferro S, Callegari C, Auriemma E, Zini E, Zappulli V. Carcinosarcoma of the biliary system in a cat. J Vet Diagn Investig. 2013;25(5):562–5.CrossRef
37.
Ghisleni G, Grieco V, Mazzotti M, Caniatti M, Roccabianca P, Scanziani E. Pulmonary carcinosarcoma in a cat. J Vet Diagn Investig. 2003;15(2):170–3.CrossRef
38.
Dunning WF, Curtis MR, Maun ME. Spontaneous malignant mixed tumors of the rat, and the successful transplantation and separation of both components from a mammary tumor. Cancer Res. 1945;5(11):644–51.
39.
Misdorp W, Else R, Héllmen E, Lipscomb T. Histologic Classification of Mammary Tumors of the Dog and Cat. World Health Organization International Classification of Tumors of Domestic Animals, 2nd Series, Vol. 7, No. 2. Washington: Armed Forces Institute of Pathology; 1999.
40.
Inomata A, Hayakawa K, Aoki T, Hosokawa S. Spontaneous carcinosarcoma originating from the renal pelvis ina rat. J Toxicol Pathol. 2016;29(3):185–9.CrossRefPubMedPubMedCentral
41.
Shahbazfar AA, Mohammadpour H, Isfahani HRE. Mammary gland carcinosarcoma in a New Zealand white rabbit (Oryctolagus cuniculus). Acta Sci Vet. 2012;40(1):1025.
42.
Misdorp W, Cotchin E, Hampe JF, Jabara AG, Von Sandersleben J. Canine malignant mammary tumors. 3. Special types of carcinomas, malignant mixed tumors. Vet Pathol. 1973;10(3):241–56.CrossRefPubMed
43.
Dantas Cassali G, Cavalheiro Bertagnolli A, Ferreira E, Araujo Damasceno K, de Oliveira Gamba C, Bonolo de Campos C. Canine mammary mixed tumours: a review. Vet Med Int. 2012;2012:274608.CrossRefPubMedPubMedCentral
44.
Lecene P. Les tumeurs mixtes du sein. Rev Chir (Paris). 1906;33:434–49.
45.
Pia-Foschini M, Reis-Filho JS, Eusebi V, Lakhani SR. Salivary gland-like tumours of the breast: surgical and molecular pathology. J Clin Pathol. 2003;56(7):497–506.CrossRefPubMedPubMedCentral
46.
Nadal P. Tumeur mixte du sein a formations malpighiennes. Bull et Mem Soc Ana de Paris. 1910;85:616–22.
47.
D'Allianes F. Tumeurs a tissus heterotopiques du sein. Ann d'Anat Path. 1928;5:361–74.
48.
Gioia T. Tumor mixto de la glandula mamaria en la hombre. Sem Med. 1930;2:1193–8.
49.
Nabert C. Epithelioma a stroma remanie ou tumeur mixte du sein : A propos d'une observation. J Sci Med Lille. 1968;86:507–10.PubMed
50.
Poluektov IA, Shestakova LM. Mixed breast tumor (case report). Vopr Onkol. 1969;15(3):99–101.PubMed
51.
Smith BH, Taylor HB. The occurrence of bone and cartilage in mammary tumors. Am J Clin Pathol. 1969;51(5):610–8.CrossRefPubMed
52.
Paikova LV. Smeshannaia opukhol' molochnykh zhelez. Arkh Pathol. 1972;34:59–61.
53.
Kermarec J. Tumeur mammaire a cellules myo-epitheliales Etude ultrastructurale. Arch Anat Pathol (Paris). 1973;21:225–31.
54.
Williams RW, Leach WB. Mixed tumor of female breast of unusual duration and size. South Med J. 1975;68(1):97–100.CrossRefPubMed
55.
Jakimowicz JJ. Three cases of rare tumors of the mammary gland. Arch Chir Neerl. 1977;29:203–8.PubMed
56.
Sheth MT, Hathway D, Petrelli M. Pleomorphic adenoma ("mixed" tumor) of human female breast mimicking carcinoma clinico-radiologically. Cancer. 1978;41(2):659–65.CrossRefPubMed
57.
Medina A. Das pleomorphe Adenom der mamma. Helv Chir Acta. 1980;47:205–8.PubMed
58.
Makek M, Von Hochstetter AR. Pleomorphic adenoma of the human breast. J Surg Oncol. 1980;14(3):281–6.CrossRefPubMed
59.
McClure J, Smith PS, Jamieson GG. Mixed' salivary type adenoma of the human female breast. Arch Pathol Lab Med. 1982;106(12):615–9.PubMed
60.
van der Walt JD, Rohlova B. Pleomorphic adenoma of the human breast. A report of a benign tumour closely mimicking a carcinoma clinically. J Clin Oncol. 1982;8(4):361–5.
61.
Spagnolo DV, Shilkin KB. Breast neoplasms containing bone and cartilage. Virchows Arch A Pathol Anat Histopathol. 1983;400(3):287–95.CrossRefPubMed
62.
Zafrani B. Tumeur mixte du sein (adenome pleomorphe). Ann Pathol. 1985;5:213–5.PubMed
63.
Cuadros CL, Ryan SS, Miller RE. Benign mixed tumor (pleomorphic adenoma) of the breast: ultrastructural study and review of the literature. J Surg Oncol. 1987;36(1):58–63.CrossRefPubMed
64.
Segen JC, Foo M. Richer S. pleomorphic adenoma of the breast with positive estrogen receptors. N Y State J Med. 1986;86(5):265–6.PubMed
65.
Willen R, Uvelius B, Cameron R. Pleomorphic adenoma in the breast of a human female. Aspiration biopsy findings and receptor determinations. Case report. Acta Chir Scand. 1986;152:709–13.PubMed
66.
Kjell HK. Pleomorphic adenoma of the human breast with local recurrence. Cancer. 1988;61:997–1001.CrossRef
67.
Ballance WA, Ro JY, El-Naggar AK, Grignon DJ, Ayala AG, Romsdahl MG. Pleomorphic adenoma (benign mixed tumor) of the breast: an immunohistochemical, flow cytometric, and ultrastructural study and review of the literature. Am J Clin Pathol. 1990;93(6):795–801.CrossRefPubMed
68.
Moran CA, Suster S, Carter D. Benign mixed tumors (pleomorphic adenomas) of the breast. Am J Surg Pathol. 1990;14(10):913–21.CrossRefPubMed
69.
70.
Nevado M, Lopez J, Dominguez MP, Ballestin C, Garcia H. Pleomorphic adenoma of the breast. APMIS. 1991;99(7–12):866–8.CrossRefPubMed
71.
Diaz NM, McDivitt RW, Wick MR. Pleomorphic adenoma of the breast: a clinicopathologic and immunohistochemical study of 10 cases. Hum Pathol. 1991;22(12):1206–14.CrossRefPubMed
72.
Simha MR, Doctor V, Udwadia T. Mixed tumour of salivary gland type of the male breast. Indian J Cancer. 1992;29(1):14–7.PubMed
73.
Agnantis N, Maounis N, Priovolou-Papaevangelou M, Baltatzis I. Pleomorphic adenoma of the human female breast. Pathol Res Pract. 1992;188(1–2):235–40.CrossRefPubMed
74.
Narita T, Matsuda K. Pleomorphic adenoma of the breast: case report and review of the literature. Pathol Int. 1995;45(6):441–7.CrossRefPubMed
75.
Mochinaga N, Yatsugi T, Tomokawa S, Ishida T, Ohtani H, Higami Y. Pleomorphic adenoma of the breast: report of a case. Surg Today. 1997;27(3):278–81.CrossRefPubMed
76.
Parham D, Evans A. Pleomorphic adenoma of the breast; a potential for the misdiagnosis of malignancy on fine needle aspiration (FNA). Cytopathology. 1998;9(5):343–8.CrossRefPubMed
77.
Fiks T. Pleomorphic adenoma (benign" mixed" tumor) of the human female breast. Case report. Pol J Pathol. 1999;50(4):297–9.PubMed
78.
Kumar PV, Sobhani SA, Monabati A, Talei AR, Shirazi B. Cytologic findings of a pleomorphic adenoma of the breast. a case report Acta Cytol. 2004;48.
79.
Sato K, Ueda Y, Shimasaki M, Ozaki M, Nitta N, Chada K, et al. Pleomorphic adenoma (benign mixed tumor) of the breast: a case report and review of the literature. Pathol Res Pract. 2005;201(4):333–9.CrossRefPubMed
80.
Molland J, Morgan G, Walker D, Lin B. Pleomorphic adenoma of the parotid and breast in a male patient. Pathology. 2005;37(3):263–5.CrossRefPubMed
81.
Dominicis E, Perrone G, Verzì A, Bianchi A, Altomare V, Zobel BB, et al. Pleomorphic adenoma of the breast. Breast J. 2005;11(6):513–4.CrossRefPubMed
82.
Iyengar P, Cody H, Brogi E. Pleomorphic adenoma of the breast: case report and review of the literature. Diagn Cytopathol. 2005;33(6):416–20.CrossRefPubMed
83.
Shum J, Obeid J, Smith P, Allevato P, Liebman S, Shum DT. Pleomorphic adenoma of the breast. Breast J. 2007;13(1):102.CrossRefPubMed
84.
Mizukami Y, Takayama T, Takemura A, Ichikawa K, Onoguchi M, Miyati T, et al. Pleomorphic adenoma of the breast. Radiat Med. 2008;26(7):442–5.CrossRefPubMed
85.
Djakovic A, Engel J, Geisinger E, Honig A, Tschammler A, Dietl J. Pleomorphic adenoma of the breast initially misdiagnosed as metaplastic carcinoma in preoperative stereotactic biopsy: a case report and review of the literature. Eur J Gynaecol Oncol. 2011;32(4):427–30.PubMed
86.
Leekha N, Muralee M, Mathews A, Preethi T, Ahamed MI. Pleomorphic adenoma of breast-a case report and review of literature. Indian J Surg Oncol. 2014;5(2):152–4.CrossRefPubMedPubMedCentral
87.
Khamechian T, Alizargar J, Mazoochi T. Reporting a rare case of pleomorphic adenoma of the breast. J Med Case Rep 2014;2014:387183.
88.
Gupta D, Agrawal S, Trivedi N, Tewari A. Pleomorphic adenoma of breast-a case report and distinction with metaplastic carcinoma. Diagn Pathol. 2015;9(2).
89.
Kelten C, Boyaci C, Trabulus DC, Sirin S. Benign mixed tumour of the breast and breast skin, two cases with diagnostic difficulties. BMJ Case Rep. 2015;2015:bcr2015210906.CrossRefPubMedPubMedCentral
90.
Ginter PS, Scognamiglio T, Tauchi-Nishi P, Antonio LB, Hoda SA. Pleomorphic adenoma of breast: a radiological and pathological study of a common tumor in an uncommon location. Case Rep Pathol. 2015;2015.
91.
Radu I, Petcu I, Pănuță A, Scripcariu D, Buna-Arvinte M, Bilavschi K, et al. Pleomorphic adenoma of the breast. Arch Clin Cases 2016;3(4).
92.
Han Y, Zhang Q, Li SX, Feng L, Zhang L, Li Z, et al. Case report pleomorphic adenoma of the breast: a report of two cases and a literature review. Int J Clin Exp Pathol. 2016;9(2):2459–65.
93.
Huvos AG, Lucas JC Jr, Foote FW Jr. Metaplastic breast carcinoma. Rare form of mammary cancer N Y State J Med. 1973;73(9):1078–82.PubMed
94.
Lehmann BD, Bauer JA, Chen X, Sanders ME, Chakravarthy AB, Shyr Y, et al. Identification of human triple-negative breast cancer subtypes and preclinical models for selection of targeted therapies. J Clin Invest. 2011;121(7):2750–67.CrossRefPubMedPubMedCentral
95.
Lim KH, Oh DY, Chie EK, Han W, Im SA, Kim TY, et al. Metaplastic breast carcinoma: clinicopathologic features and prognostic value of triple negativity. Jpn J Clin Oncol. 2010;40(2):112–8.CrossRefPubMed
96.
Al Sayed AD, El Weshi AN, Tulbah AM, Rahal MM, Ezzat AA. Metaplastic carcinoma of the breast clinical presentation, treatment results and prognostic factors. Acta Oncol. 2006;45(2):188–95.CrossRefPubMed
97.
Pezzi CM, Patel-Parekh L, Cole K, Franko J, Klimberg VS, Bland K. Characteristics and treatment of metaplastic breast cancer: analysis of 892 cases from the National Cancer Data Base. Ann Surg Oncol. 2007;14(1):166–73.CrossRefPubMed
98.
Esses KM, Hagmaier RM, Blanchard SA, Lazarchick JJ, Riker AI. Carcinosarcoma of the breast: two case reports and review of the literature. Cases J. 2009;2:15.CrossRefPubMedPubMedCentral
99.
Perez MAF, Rodriguez IV, Royloa AT, Guisasola JM. Metaplastic breast carcinoma with unusual presentation: review of three cases. Breast Care (Basel). 2015;10(6):404–7.CrossRef
100.
101.
Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast. I. Matrix-producing carcinoma. Hum Pathol. 1989;20(7):628–35.CrossRefPubMed
102.
Wargotz ES, Deos PH, Norris HJ. Metaplastic carcinomas of the breast. II. Spindle cell carcinoma. Hum Pathol. 1989;20(8):732–40.CrossRefPubMed
103.
Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast. III. Carcinosarcoma. Cancer. 1989;64(7):1490–9.CrossRefPubMed
104.
Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast. IV. Squamous cell carcinoma of ductal origin. Cancer. 1990;65(2):272–6.CrossRefPubMed
105.
Wargotz ES, Norris HJ. Metaplastic carcinomas of the breast: V. metaplastic carcinoma with osteoclastic giant cells. Hum Pathol. 1990;21(11):1142–50.CrossRefPubMed
106.
Leddy R, Irshad A, Rumboldt T, Cluver A, Campbell A, Ackerman S. Review of metaplastic carcinoma of the breast: imaging findings and pathologic features. J Clin Imaging Sci. 2012;2:21.CrossRefPubMedPubMedCentral
107.
Chuthapisith S, Warnnissorn M, Amornpinyokiat N, Pradniwat K, Angsusinha T. Metaplastic carcinoma of the breast with transformation from adenosquamous carcinoma to osteosarcomatoid and spindle cell morphology. Oncol Lett. 2013;6(3):728–32.CrossRefPubMedPubMedCentral
108.
Tot T, Badani De La Parra JJ, Bergkvist L. Metaplastic carcinoma of the breast with Neuroectodermal stromal component. Pathol Res Int. 2011;2011:1–4.
109.
Yamaguchi R, Horii R, Maeda I, Suga S, Makita M, Iwase T, et al. Clinicopathologic study of 53 metaplastic breast carcinomas: their elements and prognostic implications. Hum Pathol. 2010;41(5):679–85.CrossRefPubMed
110.
Tot T. In: Hayat MA, editor. Metaplastic breast carcinoma: detection using histology and immunohistochemistry, methods of Cancer diagnosis, therapy and prognosis, vol. 1. Berlin: Springer; 2008. p. 275–90.CrossRef
111.
Accurso A, Ciancia G, Della Corte GA, Reale P, Accardo G, Salerno C, et al. A rare case of true carcinosarcoma of the breast. Int J Surg Case Rep. 2016;21:125–8.CrossRefPubMedPubMedCentral
112.
Lai H-W, Tseng L-M, Chang T-W, Kuo Y-L, Hsieh C-M, Chen S-T, et al. The prognostic significance of metaplastic carcinoma of the breast (MCB)–a case controlled comparison study with infiltrating ductal carcinoma. Breast. 2013;22(5):968–73.CrossRefPubMed
113.
Gunhan-Bilgen I, Memis A, ÜstÜn EE, Zekioglu O, Özdemir N. Metaplastic carcinoma of the breast: clinical, mammographic, and sonographic findings with histopathologic correlation. AJR Am J Roentgenol. 2002;178(6):1421–5.CrossRefPubMed
114.
Luini A, Aguilar M, Gatti G, Fasani R, Botteri E, Brito JA, et al. Metaplastic carcinoma of the breast, an unusual disease with worse prognosis: the experience of the European Institute of Oncology and review of the literature. Breast Cancer Res Treat. 2007;101(3):349–53.CrossRefPubMed
115.
Ayar S, Dyess DL, Carter E. Matrix-producing carcinoma: a rare variant of metaplastic breast carcinoma with heterologous elements. Breast J. 2010;16(4):420–3.PubMed
116.
Schwartz TL, Mogal H, Papageorgiou C, Veerapong J, Hsueh EC. Metaplastic breast cancer: histologic characteristics, prognostic factors and systemic treatment strategies. Exp Hematol Oncol. 2013;2(1):31.CrossRefPubMedPubMedCentral
117.
Lien HC, Hsiao YH, Lin YS, Yao YT, Juan HF, Kuo WH, et al. Molecular signatures of metaplastic carcinoma of the breast by large-scale transcriptional profiling: identification of genes potentially related to epithelial-mesenchymal transition. Oncogene. 2007;26(57):7859–71.CrossRefPubMed
118.
Rungta S, Kleer CG. Metaplastic carcinomas of the breast: diagnostic challenges and new translational insights. Arch Pathol Lab Med. 2012;136(8):896–900.CrossRefPubMedPubMedCentral
119.
Marian C, Soanca D, Kinga S, Boros M, Stolnicu S. Carcinosarcoma of the breast with massive osseous malignant component: a basal-like entity with myoepithelial differentiation. Rev Romana Med Lab. 2013;21(1):67–73.
120.
Gerhard R, Ricardo S, Albergaria A, Gomes M, Silva AR, Logullo AF, et al. Immunohistochemical features of claudin-low intrinsic subtype in metaplastic breast carcinomas. Breast. 2012;21(3):354–60.CrossRefPubMed
121.
Cimino-Mathews A, Subhawong AP, Elwood H, Warzecha HN, Sharma R, Park BH, et al. Neural crest transcription factor Sox10 is preferentially expressed in triple-negative and metaplastic breast carcinomas. Hum Pathol. 2013;44(6):959–65.CrossRefPubMed
122.
Hennessy B, Giordano S, Broglio K, Duan Z, Trent J, Buchholz T, et al. Biphasic metaplastic sarcomatoid carcinoma of the breast. Ann Oncol. 2006;17(4):605–13.CrossRefPubMed
123.
Shah DR, Tseng WH, Martinez SR. Treatment options for metaplastic breast cancer. ISRN oncology. 2012;2012:1–4.CrossRef
124.
Mitus JW, Sas-Korczyńska B, Kruczak A, Jasiówka M, Ryś J. Metaplastic breast cancer with rapidly progressive recurrence in a young woman: case report and review of the literature. Arch Med Sci. 2016;12(6):1384–8.CrossRefPubMedPubMedCentral
125.
Saad ES, Milley KM, Al-Khan AA, Nimmo JS, Bacci B, Tayebi M, et al. Canine mixed mammary tumour as a model for human breast Cancer with osseous metaplasia. J Comp Pathol. 2017;156(4):352–65.CrossRefPubMed
126.
Goldschmidt M, Pena L, Rasotto R, Zappulli V. Classification and grading of canine mammary tumors. Vet Pathol. 2011;48(1):117–31.CrossRefPubMed
127.
Browne J, Ramsey F. Mixed mammary gland tumor studies in an aged dog. Iowa State Univ Vet. 1960;22(3):4.
128.
Mulligan RM. Neoplasms of the dog. The Williams And Wilkins Company: Baltimore; 1949.
129.
Baba AI, Catoi C, Mammary gland tumors, Chapter 11. Comparative Oncology Bucharest: Publishing House of the Romanian Academy; 2007.
130.
Cassali G, Lavalle G, De Nardi A, Ferreira E, Bertagnolli A, Estrela-Lima A, et al. Consensus for the diagnosis, prognosis and treatment of canine mammary tumors. Braz J Vet Pathol. 2011;4(2):153–80.
131.
Campos C, LavalleGE LS, MonteiroLN AR, Cassali G. Thalidomide treatment in a canine mammary gland carcinosar-coma presenting pulmonary metastasis. Adv Anim Vet Sci. 2017;5(3):120–6.CrossRef
132.
Sassi F, Benazzi C, Castellani G, Sarli G. Molecular-based tumour subtypes of canine mammary carcinomas assessed by immunohistochemistry. BMC Vet Res. 2010;6:5.CrossRefPubMedPubMedCentral
133.
Gama A, Alves A, Schmitt F. Identification of molecular phenotypes in canine mammary carcinomas with clinical implications: application of the human classification. Virchows Arch. 2008;453(2):123–32.CrossRefPubMed
134.
Graf R, Grüntzig K, Boo G, Hässig M, Axhausen K, Fabrikant S, et al. Swiss feline Cancer registry 1965–2008: the influence of sex, breed and age on tumour types and tumour locations. J Comp Pathol. 2016;154(2):195–210.CrossRefPubMed
135.
Wypij J, Fan TM. Louis-Philippe de Lorimier D. malignant mammary tumors: biologic behavior, prognostic factors, and therapeutic approach in cats. Urbana. 2006;51:61802.
136.
Weijer K, Head K, Misdorp W, Hampe J. Feline malignant mammary tumors. I. Morphology and biology: some comparisons with human and canine mammary carcinomas. J Natl Cancer Inst. 1972;49(6):1697–704.CrossRefPubMed
137.
Sanchez J, Buendía A, Vilafranca M, Velarde R, Altimara J, Martínez C, et al. Canine carcinosarcomas in the head. Vet Pathol. 2005;42(6):828–33.CrossRefPubMed
138.
Fusaro L, Panarese S, Brunetti B, Zambelli D, Benazzi C, Sarli G. Quantitative analysis of telomerase in feline mammary tissues. J Vet Diagn Investig. 2009;21(3):369–73.CrossRef
139.
Rehm S, Ward JM, Liebelt AG. In: Jones TC, Moher U, Hunt RD, editors. Mixed adenocarcinoma, mammary gland, mouse. Integument and mammary glands. Berlin: Springer; 1989. p. 323–8.CrossRef
140.
Isfahani HRE. Mammary gland carcinosarcoma in a New Zealand white rabbit (Oryctolagus cuniculus). Acta Sci Vet. 2012;40(1):1025.
141.
Falomo ME, Rasotto R, Isola M. Mammary carcinosarcoma in a pony mare. Ippologia. 2013;24(1):23–9.
142.
Shivaprasad HL, Sundberg JP, Ely R. Malignant mixed (Carcinosarcoma) mammary tumor in a gray squirrel. Vet Pathol. 1984;21(1):115–7.CrossRefPubMed
143.
Munson L, Moresco A. Comparative pathology of mammary gland cancers in domestic and wild animals. Breast dis. 2007;28(1):7–21.CrossRefPubMed
144.
Sadler RA, Craig LE, Ramsay EC, Helmick K, Collins D, Garner MM. Clinicopathologic features of mammary masses in captive lions (Panthera Leo). J Zoo Wildl Med. 2016;47(1):127–31.CrossRefPubMed
145.
Hruban Z, Carter WE, Meehan T, Wolff P, Franklin WA, Glagov S. Complex mammary carcinoma in a tiger (Panthera tigris). The Journal of Zoo Animal Medicine. 1988;19:226–30.CrossRef
146.
Tyndale-Biscoe H, Renfree M. Reproductive physiology of marsupials. Cambridge: Cambridge University Press; 1987. p. 476.CrossRef
147.
Gwin K, Buell-Gutbrod R, Tretiakova M, Montag A. Epithelial-to-mesenchymal transition in metaplastic breast carcinomas with chondroid differentiation: expression of the E-cadherin repressor snail. Appl Immunohistochem Mol Morphol. 2010;18(6):526–31.CrossRefPubMed
148.
Zavadil J, Böttinger EP. TGF-β and epithelial-to-mesenchymal transitions. Oncogene. 2005;24(37):5764–74.CrossRefPubMed
149.
Zhuang Z, Lininger RA, Man YG, Albuquerque A, Merino MJ, Tavassoli FA. Identical clonality of both components of mammary carcinosarcoma with differential loss of heterozygosity. Mod Pathol. 1997;10(4):354–62.PubMed
150.
Thompson L, Chang B, Barsky SH. Monoclonal origins of malignant mixed tumors (carcinosarcomas). Evidence for a divergent histogenesis Am J Surg Pathol. 1996;20(3):277–85.CrossRefPubMed
151.
Wang X, Mori I, Tang W, Yang Q, Nakamura M, Nakamura Y, et al. Metaplastic carcinoma of the breast: p53 analysis identified the same point mutation in the three histologic components. Mod Pathol. 2001;14(11):1183–6.CrossRefPubMed
152.
Wada H, Enomoto T, Tsujimoto M, Nomura T, Murata Y, Shroyer KR. Carcinosarcoma of the breast: molecular-biological study for analysis of histogenesis. Hum Pathol. 1998;29(11):1324–8.CrossRefPubMed
153.
Reis-Filho JS, Schmitt FC. p63 expression in sarcomatoid/metaplastic carcinomas of the breast. Histopathology. 2003;42(1):94–5.CrossRefPubMed
154.
Leibl S, Gogg-Kammerer M, Sommersacher A, Denk H, Moinfar F. Metaplastic breast carcinomas: are they of myoepithelial differentiation?: immunohistochemical profile of the sarcomatoid subtype using novel myoepithelial markers. Am J Surg Pathol. 2005;29(3):347–53.CrossRefPubMed
155.
Bartels S, van Luttikhuizen JL, Christgen M, Magel L, Luft A, Hanzelmann S, et al. CDKN2A loss and PIK3CA mutation in myoepithelial-like metaplastic breast cancer. J Pathol. 2018;245(3):373–83.CrossRefPubMed
156.
Bloom F. Pathology of the dog and cat. The genitourinary system, with clinical considerations. Illinois: Evanston, Ill.: American Veterinary Publications, Inc.; 1954. pp. 418–424.
157.
Allen AC. So-called mixed tumors of the mammary gland of dog and man. With special reference to the general problem of cartilage and bone formation. Arch Pathol. 1940;29:589–624.
158.
Gartner F, Geraldes M, Cassali G, Rema A, Schmitt F. DNA measurement and immunohistochemical characterization of epithelial and mesenchymal cells in canine mixed mammary tumours: putative evidence for a common histogenesis. Vet J. 1999;158(1):39–47.CrossRefPubMed
159.
Ramalho L, Ribeiro-Silva A, Cassali G, Zucoloto S. The expression of p63 and cytokeratin 5 in mixed tumors of the canine mammary gland provides new insights into the histogenesis of these neoplasms. Vet Pathol. 2006;43(4):424–9.CrossRefPubMed
160.
de Los Monteros AE, Millán M, Ordás J, Carrasco L, Reymundo C, de Las Mulas JM. Immunolocalization of the smooth muscle-specific protein calponin in complex and mixed tumors of the mammary gland of the dog: assessment of the morphogenetic role of the myoepithelium. Vet Pathol. 2002;39(2):247–56.CrossRef
161.
Destexhe E, Bicker E, Coignoul F. Image analysis evaluation of ploidy, S-phase fraction and nuclear area in canine mammary tumours. J Comp Pathol. 1995;113(3):205–16.CrossRefPubMed
162.
Gama A, Alves A, Gartner F, Schmitt F. p63: a novel myoepithelial cell marker in canine mammary tissues. Vet Pathol. 2003;40(4):412–20.CrossRefPubMed
163.
Cassali G, Bertagnolli A, Gärtner F, Schmitt F. Canine mammary tumours: a quantitative DNA study using static cytometry. Rev Esp Patol. 2011;44(4):195–201.
164.
Bertagnolli AC, Soares P, van Asch B, Amorim A, Cirnes L, Maximo V, et al. An assessment of the clonality of the components of canine mixed mammary tumours by mitochondrial DNA analysis. Vet J. 2009;182(2):269–74.CrossRefPubMed
165.
Huggins C, Moulder PV. Studies on the mammary tumors of dogs. I. Lactation and the influence of ovariectomy and suprarenalectomy thereon. J Exp Med. 1944;80(5):441–54.CrossRefPubMedPubMedCentral
Metadaten
Titel
A Comparative Review of Mixed Mammary Tumors in Mammals
verfasst von
Eman S. A. Saad
Jacqueline S. Y. Lam
Awf A. Al-Khan
Mourad Tayebi
Michael J. Day
Samantha J. Richardson
Janine A. Danks
Publikationsdatum
28.11.2018
Verlag
Springer US
Erschienen in
Journal of Mammary Gland Biology and Neoplasia / Ausgabe 2/2019
Print ISSN: 1083-3021
Elektronische ISSN: 1573-7039
DOI
https://doi.org/10.1007/s10911-018-9422-2

Weitere Artikel der Ausgabe 2/2019

Journal of Mammary Gland Biology and Neoplasia 2/2019 Zur Ausgabe

ReviewPaper

Metformin and Breast Cancer: Molecular Targets

OriginalPaper

Mammary Epithelial Cell Lineage Changes During Cow’s Life

OriginalPaper

Detection of Milk Ejection Using Bioimpedance Spectroscopy in Lactating Women during Milk Expression Using an Electric Breast Pump

OriginalPaper

A Syngeneic ErbB2 Mammary Cancer Model for Preclinical Immunotherapy Trials

ReviewPaper

Application of the D492 Cell Lines to Explore Breast Morphogenesis, EMT and Cancer Progression in 3D Culture

OriginalPaper

A Longitudinal Study of the Association between Mammographic Density and Gene Expression in Normal Breast Tissue

Neu im Fachgebiet Onkologie

Bessere Prognose mit links- statt rechtsseitigem Kolon-Ca.

06.05.2024 Kolonkarzinom Nachrichten

Menschen mit linksseitigem Kolonkarzinom leben im Mittel zweieinhalb Jahre länger als solche mit rechtsseitigem Tumor. Auch aktuell ist das Sterberisiko bei linksseitigen Tumoren US-Daten zufolge etwa um 11% geringer als bei rechtsseitigen.

Nodal-negativ nach neoadjuvanter Chemo: Axilladissektion verzichtbar?

03.05.2024 Mammakarzinom Nachrichten

Wenn bei Mammakarzinomen durch eine neoadjuvante Chemotherapie ein Downstaging von nodal-positiv zu nodal-negativ gelingt, scheint es auch ohne Axilladissektion nur selten zu axillären Rezidiven zu kommen.

Wo hapert es noch bei der Umsetzung der POMGAT-Leitlinie?

03.05.2024 DCK 2024 Kongressbericht

Seit November 2023 gibt es evidenzbasierte Empfehlungen zum perioperativen Management bei gastrointestinalen Tumoren (POMGAT) auf S3-Niveau. Vieles wird schon entsprechend der Empfehlungen durchgeführt. Wo es im Alltag noch hapert, zeigt eine Umfrage in einem Klinikverbund.

Bestrahlung nach Prostatektomie: mehr Schaden als Nutzen?

02.05.2024 Prostatakarzinom Nachrichten

Eine adjuvante Radiotherapie nach radikaler Prostata-Op. bringt den Betroffenen wahrscheinlich keinen Vorteil. Im Gegenteil: Durch die Bestrahlung steigt offenbar das Risiko für Harn- und Stuhlinkontinenz.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen
Bildnachweise